NCT06987942 - Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion) | Biotech Hunter

Enrollment

899

Participants

Timeline

Start Date

September 21, 2024

Primary Completion Date

November 15, 2024

Study Completion Date

November 15, 2024

Conditions

VaricellaInfluenza Vaccine

Interventions

BIOLOGICAL

Varicella vaccine+TIV

"* Varicella vaccine: lyophilized powder, subcutaneous injection~* TIV: Inactived, split virion, containing H1N1, H3N2 and BV strains."

BIOLOGICAL

Varicella vaccine

lyophilized powder, subcutaneous

BIOLOGICAL

TIV

Inactived, split virion, containing H1N1, H3N2 and BV strains.

Trial Locations (1)

Jiangsu Provincial Center for Disease control and Prevention, Nanjing

All Listed Sponsors

lead

Sinovac (Dalian) Vaccine Technology Co., Ltd.

INDUSTRY